Professor Lee Ji-woo of Seoul National University College of Pharmacy Receives 'Handok Academic Award'

Professor Jiwoo Lee of Seoul National University College of Pharmacy, selected as the recipient of the 53rd Korea-Germany Academic Award

[Asia Economy Reporter Chunhee Lee] Handok and the Korean Pharmaceutical Society announced on the 19th that Professor Jiwoo Lee of Seoul National University College of Pharmacy has been selected as the recipient of the 53rd Handok Academic Award.

The Handok Academic Award is an award jointly established by Handok and the Korean Pharmaceutical Society in 1970. It is awarded annually to researchers who have dedicated themselves to the advancement of pharmaceutical sciences in Korea through active activities and outstanding research achievements to encourage research enthusiasm in the field of pharmacy. The award ceremony for the 53rd Handok Academic Award will be held on the 20th at Jeju Shinhwa World. Professor Lee, the selected recipient, will receive a prize of 20 million KRW and the Yakyeontap (Pharmaceutical Tower) award.

Professor Lee is recognized as an expert in innovative drug development, particularly in the discovery and development of new drug candidates. He has gained attention domestically and internationally for his achievements in technology transfer to multinational pharmaceutical companies, especially in the fields of Alzheimer's disease and neuropathic pain treatment, which are currently receiving significant interest.

With outstanding research achievements, Professor Lee has published over 200 international SCI papers and has actively conducted research activities, including publishing 30 research papers in the Journal of Medicinal Chemistry (JMC), one of the top journals in the pharmaceutical and chemistry fields. His excellent research accomplishments have been internationally recognized, and he currently serves as an editorial board member for three major journals in medicinal chemistry: JMC, Bioorganic & Medicinal Chemistry (BMC), and Bioorganic & Medicinal Chemistry Letters (BMCL).

In addition, as a professor at Seoul National University College of Pharmacy, he is dedicated to educating and training specialized personnel in new drug development. He also contributes to enhancing the capabilities of corporate researchers through lectures at domestic pharmaceutical companies seeking specialized education in medicinal chemistry. Furthermore, he actively participates in international academic activities and serves as the president of the Asia Federation of Medicinal Chemistry (AFMC), one of the three major medicinal chemistry federations. He is preparing to host the large-scale international conference AIMECS 2023 in Korea next year, significantly contributing to raising the status of the pharmaceutical society.

This content was produced with the assistance of AI translation services.